Medicover: Still Expecting Good Results

Research Note

2020-03-25

12:15

In view of the corona-crisis, a review of the Medicover case makes us conclude that the current stock weakness is overdone and represents an opportunity to build exposure at an attractive price. While fundamental risks admittedly have risen of late, however, we leave our estimates unchanged at this point still predicting solid results for the year as a whole.

GA

Gergana Almquist

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.